Amgen shares top $100 as fears fade over biosimilars | Pacific Coast Business Times

PPB

Montecito

Powershare

Loading...

You are here: Home > Banking & Finance > Current Article

Amgen shares top $100 as fears fade over biosimilars

By Stephen Nellis / Friday, April 5th, 2013 / Comments Off on Amgen shares top $100 as fears fade over biosimilars

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.

NEXT ARTICLE →
Up in the air: When it makes sense to take your small business into the cloud

← PREVIOUS ARTICLE
Green Coast 2013: How the region is leading the way in energy efficiency

About the author

Stephen Nellis

Senior editor

View all articles by Stephen Nellis »

Related Articles

Friday, September 14th, 2018

Thomas Aquinas College acquires 714 acres of land

Friday, September 7th, 2018

Life sciences venture fund has confidence in region

Friday, September 7th, 2018

Amgen pilots new drug strategy after investing in T.O. campus

You might also like...

Semtech invests in printable battery technology firm